Aim: To determine the frequency of NOD2 gene c.3019-3020insC (rs5743293) and c.2104C>T (rs2066844) allelic variants in the patients with Crohn's disease (CD), colorectal cancer (CRC) and in the control groups and to study the association of these mutations with the onset time of the diseases, gender and surgical interventions.
Materials And Methods: The diagnoses of CD and CRC were established based on standard clinical examination and laboratory tests. Molecular genetic study of a frameshift 3020insC mutations of NOD2 gene were performed in 54 patients with CD; missense R702W mutations of the NOD2 gene - in 41 CD patients and 38 healthy controls. In CRC group, 3020insC mutation was tested in 48 patients, R702W mutation - in 40 patients and 40 healthy controls. PCR-RFLP technique was used to identify the mutations.
Results: The frequency of the minor allele (M) of 3020insC mutation of NOD2 gene in the patients with CD was significantly higher than in the control group (р = 0.01). The age at CD onset in females carrying 3020insC mutation was significantly lower (22.5 ± 1.6 years) when compared with females without the mutation (32.7 ± 2.5 years) (p = 0.002). There was no significant difference in the allele frequencies and genotype distributions of R702W mutation in the patients with CD in comparison with the controls. The mean age at CD onset in the patients carrying R702W mutation was significantly lower (28.4 ± 1.4 years) compared with the patients without the mutation (39.4 ± 2.8 years) (p < 0.01). Surgical interventions for CD was required in 40.0% of 3020insC mutation carriers. Among patients with CRC, only 4.2% carried 3020insC mutation and 20.0% R702W mutation. Our study suggests that R702W and 3020insC mutations are not associated with the risk of CRC in Ukrainian patients. There was no statistically significant difference in mean age at CRC onset in patients with/without R702W mutation. Only one patient with CRC had two mutations.
Conclusion: The earlier age at CD onset was associated with 3020insC mutation, but only in female patients. The association between R702W mutation and the earlier age of CD onset was found. Patients with 3020insC mutation showed a trend to a higher frequency of surgical interventions for CD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-1.17305 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Presence of NOD2 mutations is not associated with hepatic or systemic hemodynamic abnormalities of cirrhosis.
Dig Liver Dis
October 2023
Internal Medicine IV, Jena University Hospital, Jena, Germany. Electronic address:
Background: Patients with cirrhosis who carry NOD2 mutations are susceptible to bacterial infections. The aim was to evaluate the association of NOD2 mutations with hepatic and systemic hemodynamics in cirrhosis.
Patients And Methods: This is a secondary analysis of a prospectively collected database in the context of the screening for the INCA trial (EudraCT 2013-001626-26).
Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men.
Cancer Control
June 2022
Faculty of Medicine, Department of Clinical Genetics, Collegium Medicum in Bydgoszcz, 49604Nicolaus Copernicus University in Toruń, Poland.
We tested the association of germline variants in , , , , , , , , and genes, as well as in 8q24 region, with prostate cancer (PC) risk and estimated their impact on disease clinical course, including overall survival time in Polish men with localized PC qualified for radical treatment. DNA of 110 patients with localized prostate cancer treated with radical prostatectomy (RP), from each age group and with different stages of the disease. DNA samples of the control group consisted of 111 men, volunteers, without PC (age-matched to study group).
View Article and Find Full Text PDFAim: To determine the frequency of NOD2 gene c.3019-3020insC (rs5743293) and c.2104C>T (rs2066844) allelic variants in the patients with Crohn's disease (CD), colorectal cancer (CRC) and in the control groups and to study the association of these mutations with the onset time of the diseases, gender and surgical interventions.
View Article and Find Full Text PDFThe Impact of the Variant (3020insC) and Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma.
Biomed Res Int
March 2021
Department of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, Poland.
Introduction: Multiple myeloma (MM) is a hematological malignancy characterized by genetic variety. The 3020insC variant of the gene results in the upregulation of proinflammatory cytokines. Chronic inflammation and abnormal function of the proteasome system may lead to MM development.
View Article and Find Full Text PDFCrohn's disease - genetic factors and progress of the disease.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
June 2018
Department of Internal Medicine, University Hospital Ostrava, Czech Republic.
Article Synopsis
- Crohn's disease is a complex inflammatory condition primarily affecting the gastrointestinal tract, with genetic factors, particularly mutations in the NOD2/CARD15 gene, believed to play a role in disease expression.
- A study analyzed 70 Crohn's patients to see if specific gene mutations (R702W, G908R, 3020insC) were linked to the disease's clinical characteristics, finding that 32% had at least one mutation.
- Results showed no significant differences in disease traits between those with or without mutations, though homozygotes for 3020insC were identified as a high-risk group, suggesting the mutations don't notably affect disease phenotype or reoperation rates.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!